HealthInvest Partners’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Sell |
20,158
-3,333
| -14% | -$458K | 1.19% | 27 |
|
|
2025
Q1 | $4.24M | Buy |
23,491
+14,289
| +155% | +$2.58M | 1.87% | 19 |
|
|
2024
Q4 | $1.47M | Hold |
9,202
| – | – | 0.7% | 28 |
|
|
2024
Q3 | $1.68M | Buy |
9,202
+1,578
| +21% | +$287K | 0.79% | 28 |
|
|
2024
Q2 | $1.4M | Buy |
7,624
+1,000
| +15% | +$184K | 0.85% | 28 |
|
|
2024
Q1 | $1.18M | Hold |
6,624
| – | – | 0.72% | 32 |
|
|
2023
Q4 | $822K | Buy |
+6,624
| New | +$822K | 0.64% | 33 |
|
|
2022
Q4 | $11K | Buy |
+139
| New | +$11K | 0.02% | 38 |
|